0 XP   0   0   0

Roche Holding AG Participation
Buy or Sell?

Welcome Invester! I guess you are interested in Roche Holding AG Participation. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

Let's start. I'm going to help you getting a better view of Roche Holding AG Participation. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

  1. Company's Financial Health
    A deep dive into the books. How are the numbers doing? Is Roche Holding AG Participation even making a profit? Is the company skyrocketing? Or is it sinking like the Titanic. The trend is your friend.
  2. Market Valuation
    Finally, you now have an insight of how Roche Holding AG Participation is doing in the market. If the company is worth buying. The latest step is to find out how other investors value Roche Holding AG Participation. The closing price on 2022-09-29 was $335.00 per share. Is the company over- or underpriced?
  3. Key Performance Indicators
    A total overlook on how the company is doing. Based on the (trends in) the key performance indicators.
Roche Holding AG Participation Daily Candlestick Chart


Summary

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is less efficient in making profit.
Using its investors money, the company is less efficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is just able to pay all its short-term debts.
The company is just not able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is just not able to pay all its debts with equity.

1.1. Profitability of Roche Holding AG Participation.

1.1. Profitability

An important factor of a company's health is the profitability.

1.1.1. Net Profit Margin

Measures how much net profit Roche earns for each $1 of revenue.

  • Above 10% is considered healthy but always compare Roche to the Drug Manufacturers-General industry mean.
  • A Net Profit Margin of 0.0% means that $0.00 for each $1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Roche Holding AG Participation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y8.9%-8.9%
5Y8.9%10Y9.9%-1.0%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-12.9%-12.9%
TTM-14.7%-14.7%
YOY-13.2%-13.2%
5Y8.9%13.0%-4.1%
10Y9.9%14.9%-5.0%
1.1.2. Return on Assets

Shows how efficient Roche is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Roche to the Drug Manufacturers-General industry mean.
  • 4.1% Return on Assets means that Roche generated $0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Roche Holding AG Participation:

  • The MRQ is 4.9%. Using its assets, the company is less efficient in making profit.
  • The TTM is 4.1%. Using its assets, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ4.9%TTM4.1%+0.8%
TTM4.1%YOY4.1%0.0%
TTM4.1%5Y3.9%+0.2%
5Y3.9%10Y3.9%+0.0%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ4.9%1.8%+3.1%
TTM4.1%2.3%+1.8%
YOY4.1%1.8%+2.3%
5Y3.9%2.0%+1.9%
10Y3.9%2.1%+1.8%
1.1.3. Return on Equity

Shows how efficient Roche is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Roche to the Drug Manufacturers-General industry mean.
  • 16.9% Return on Equity means the company generated $0.17 for each $1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Roche Holding AG Participation:

  • The MRQ is 16.9%. Using its investors money, the company is efficient in making profit. +1
  • The TTM is 13.7%. Using its investors money, the company is less efficient in making profit.
Trends
Current periodCompared to+/- 
MRQ16.9%TTM13.7%+3.2%
TTM13.7%YOY9.9%+3.9%
TTM13.7%5Y11.0%+2.8%
5Y11.0%10Y11.1%-0.1%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ16.9%4.4%+12.5%
TTM13.7%4.9%+8.8%
YOY9.9%4.8%+5.1%
5Y11.0%4.6%+6.4%
10Y11.1%4.6%+6.5%

1.2. Operating Efficiency of Roche Holding AG Participation.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Roche is operating .

  • Measures how much profit Roche makes for each $1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Roche to the Drug Manufacturers-General industry mean.
  • An Operating Margin of 0.0% means the company generated $0.00  for each $1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Roche Holding AG Participation:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y15.7%-15.7%
5Y15.7%10Y17.4%-1.6%
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-17.2%-17.2%
TTM-17.2%-17.2%
YOY-17.2%-17.2%
5Y15.7%18.2%-2.5%
10Y17.4%17.6%-0.2%
1.2.2. Operating Ratio

Measures how efficient Roche is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • An Operation Ratio of 0.0% means that the operating costs are $0.00for each $1 in net sales.

Let's take a look of the Operating Ratio trends of Roche Holding AG Participation:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y0.482-0.482
5Y0.48210Y0.524-0.042
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ-1.091-1.091
TTM-1.020-1.020
YOY-0.950-0.950
5Y0.4820.960-0.478
10Y0.5240.869-0.345

1.3. Liquidity of Roche Holding AG Participation.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Roche is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Current Ratio of 110.6% means the company has $1.11 in assets for each $1 in short-term debts.

Let's take a look of the Current Ratio trends of Roche Holding AG Participation:

  • The MRQ is 1.106. The company is just able to pay all its short-term debts.
  • The TTM is 1.017. The company is just able to pay all its short-term debts.
Trends
Current periodCompared to+/- 
MRQ1.106TTM1.017+0.089
TTM1.017YOY1.269-0.252
TTM1.0175Y1.259-0.242
5Y1.25910Y1.262-0.003
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ1.1061.432-0.326
TTM1.0171.398-0.381
YOY1.2691.420-0.151
5Y1.2591.392-0.133
10Y1.2621.381-0.119
1.3.2. Quick Ratio

Measures if Roche is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy (always compare to Drug Manufacturers-General industry mean)
  • A Quick Ratio of 49.5% means the company can pay off $0.50 for each $1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Roche Holding AG Participation:

  • The MRQ is 0.495. The company is just not able to pay all its short-term debts with the most liquid assets. -1
  • The TTM is 0.429. The company is just not able to pay all its short-term debts with the most liquid assets. -1
Trends
Current periodCompared to+/- 
MRQ0.495TTM0.429+0.066
TTM0.429YOY0.560-0.130
TTM0.4295Y0.604-0.175
5Y0.60410Y0.607-0.002
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.4950.849-0.354
TTM0.4290.810-0.381
YOY0.5600.788-0.228
5Y0.6040.851-0.247
10Y0.6070.765-0.158

1.4. Solvency of Roche Holding AG Participation.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Roche assets are financed with debt.

  • Below 1 (100%) is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Debt to Asset Ratio of 0.67 means that Roche assets are financed with 66.6% credit (debt) and the remaining percentage (100% - 66.6%) is financed by its owners/shareholders.

Let's take a look of the Debt to Asset Ratio trends of Roche Holding AG Participation:

  • The MRQ is 0.666. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.645. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.666TTM0.645+0.021
TTM0.645YOY0.543+0.102
TTM0.6455Y0.597+0.048
5Y0.59710Y0.602-0.005
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ0.6660.487+0.179
TTM0.6450.503+0.142
YOY0.5430.540+0.003
5Y0.5970.525+0.072
10Y0.6020.517+0.085
1.4.2. Debt to Equity Ratio

Measures if Roche is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A Debt to Equity ratio of 229.4% means that company has $2.29 debt for each $1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Roche Holding AG Participation:

  • The MRQ is 2.294. The company is just not able to pay all its debts with equity.
  • The TTM is 2.187. The company is just not able to pay all its debts with equity.
Trends
Current periodCompared to+/- 
MRQ2.294TTM2.187+0.107
TTM2.187YOY1.306+0.880
TTM2.1875Y1.693+0.494
5Y1.69310Y1.724-0.032
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ2.2940.952+1.342
TTM2.1871.033+1.154
YOY1.3061.157+0.149
5Y1.6931.140+0.553
10Y1.7241.089+0.635

2. Market Valuation of Roche Holding AG Participation

2. Earnings
2.1. Price to Earnings Ratio

Measures how many years it takes to double your invested money in Roche.

  • Above 15 is considered overpriced but is hard to determine (always use industry average).
  • A PE ratio of 18.87 means the investor is paying $18.87 for every $1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Roche Holding AG Participation:

  • The EOD is 19.151. Neutral. Compare to industry.
  • The MRQ is 18.865. Neutral. Compare to industry.
  • The TTM is 22.488. Neutral. Compare to industry.
Trends
Current periodCompared to+/- 
EOD19.151MRQ18.865+0.286
MRQ18.865TTM22.488-3.622
TTM22.488YOY21.005+1.482
TTM22.4885Y19.869+2.619
5Y19.86910Y18.062+1.806
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
EOD19.15114.897+4.254
MRQ18.86517.928+0.937
TTM22.48819.640+2.848
YOY21.00521.657-0.652
5Y19.86921.014-1.145
10Y18.06220.535-2.473
2.2. Price Earnings to Growth Ratio

Measures the predicted future growth of Roche.

  • Lower is better
  • A PEG ratio of 1 means the investor is paying a fair price for the stock

Let's take a look of the Price Earnings to Growth Ratio trends of Roche Holding AG Participation:

  • The MRQ is 2.889. Seems overpriced? -1
  • The TTM is 6.728. Seems overpriced? -1
Trends
Current periodCompared to+/- 
MRQ2.889TTM6.728-3.839
TTM6.728YOY14.123-7.395
TTM6.7285Y6.447+0.280
5Y6.44710Y6.4470.000
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
MRQ2.8890.086+2.803
TTM6.7280.002+6.726
YOY14.123-0.076+14.199
5Y6.447-0.048+6.495
10Y6.4470.003+6.444

2. Books
2.3. Price to Book Ratio

Measures if the stock price of Roche is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Drug Manufacturers-General industry mean).
  • A PB ratio of 9.13 means the investor is paying $9.13 for each $1 in book value.

Let's take a look of the Price to Book Ratio trends of Roche Holding AG Participation:

  • The EOD is 9.265. Seems overpriced? -1
  • The MRQ is 9.127. Seems overpriced? -1
  • The TTM is 10.234. Seems overpriced? -1
Trends
Current periodCompared to+/- 
EOD9.265MRQ9.127+0.138
MRQ9.127TTM10.234-1.107
TTM10.234YOY7.582+2.652
TTM10.2345Y4.755+5.478
5Y4.75510Y4.323+0.432
Compared to industry (Drug Manufacturers-General)
PeriodCompanyIndustry (mean)+/- 
EOD9.2652.884+6.381
MRQ9.1273.222+5.905
TTM10.2343.587+6.647
YOY7.5823.578+4.004
5Y4.7553.166+1.589
10Y4.3233.020+1.303

2.4. Latest News of Roche Holding AG Participation

Does Roche Holding AG Participation still have the same value as the quarterly reports suggest? Recent changes may be an indication that the value of the company is changing. Read the news from Roche Holding AG Participation to keep up to date. Note: the news is often already included in the price.

DateTitleRead
2022-09-09
21:58
Regeneron's Eylea Win Leaves an Elephant in the RoomRead

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Roche Holding AG Participation compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Gains Per Share--2.976-3.086+204%1.941+53%3.287-9%3.287-9%
Book Value Per Share--36.15637.755-4%45.620-21%22.903+58%20.821+74%
Current Ratio--1.1061.017+9%1.269-13%1.259-12%1.262-12%
Debt To Asset Ratio--0.6660.645+3%0.543+23%0.597+12%0.602+11%
Debt To Equity Ratio--2.2942.187+5%1.306+76%1.693+36%1.724+33%
Dividend Per Share--4.7924.566+5%4.552+5%4.134+16%4.134+16%
Eps--5.3274.373+22%4.105+30%3.824+39%3.714+43%
Gains Per Share--7.7671.479+425%6.493+20%7.421+5%7.421+5%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Net Profit Margin----0%-0%0.089-100%0.099-100%
Operating Margin----0%-0%0.157-100%0.174-100%
Operating Ratio----0%-0%0.482-100%0.524-100%
Pb Ratio9.265+1%9.12710.234-11%7.582+20%4.755+92%4.323+111%
Pe Ratio19.151+1%18.86522.488-16%21.005-10%19.869-5%18.062+4%
Peg Ratio--2.8896.728-57%14.123-80%6.447-55%6.447-55%
Price Per Share335.000+1%330.000375.213-12%344.623-4%308.046+7%303.155+9%
Quick Ratio--0.4950.429+15%0.560-12%0.604-18%0.607-18%
Return On Assets--0.0490.041+20%0.041+20%0.039+25%0.039+26%
Return On Equity--0.1690.137+23%0.099+72%0.110+54%0.111+53%
 EOD+0 -3MRQTTM+12 -3YOY+9 -65Y+9 -910Y+8 -10

3.2. Fundamental Score

Let's check the fundamental score of Roche Holding AG Participation based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-1519.151
Price to Book Ratio (EOD)Between0-19.265
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than10.495
Current Ratio (MRQ)Greater than11.106
Debt to Asset Ratio (MRQ)Less than10.666
Debt to Equity Ratio (MRQ)Less than12.294
Return on Equity (MRQ)Greater than0.150.169
Return on Assets (MRQ)Greater than0.050.049
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Roche Holding AG Participation based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5054.800
Ma 20Greater thanMa 50326.023
Ma 50Greater thanMa 100328.592
Ma 100Greater thanMa 200327.808
OpenGreater thanClose311.470
Total2/5 (40.0%)



Latest Balance Sheet

Balance Sheet of 2022-06-30. Currency in CHF. All numbers in thousands.

Summary
Total Assets86,736,000
Total Liabilities57,790,000
Total Stockholder Equity25,189,000
 As reported
Total Liabilities 57,790,000
Total Stockholder Equity+ 25,189,000
Total Assets = 86,736,000

Assets

Total Assets86,736,000
Total Current Assets30,321,000
Long-term Assets30,321,000
Total Current Assets
Cash And Cash Equivalents 4,315,000
Short-term Investments 2,493,000
Net Receivables 11,078,000
Inventory 8,292,000
Other Current Assets 4,143,000
Total Current Assets  (as reported)30,321,000
Total Current Assets  (calculated)30,321,000
+/-0
Long-term Assets
Property Plant Equipment 24,324,000
Goodwill 11,160,000
Intangible Assets 11,735,000
Other Assets 9,196,000
Long-term Assets  (as reported)56,415,000
Long-term Assets  (calculated)56,415,000
+/-0

Liabilities & Shareholders' Equity

Total Current Liabilities27,409,000
Long-term Liabilities30,381,000
Total Stockholder Equity25,189,000
Total Current Liabilities
Short Long Term Debt 5,381,000
Accounts payable 3,896,000
Other Current Liabilities 18,132,000
Total Current Liabilities  (as reported)27,409,000
Total Current Liabilities  (calculated)27,409,000
+/-0
Long-term Liabilities
Long term Debt 22,369,000
Other Liabilities 6,665,000
Long-term Liabilities Other 1,347,000
Long-term Liabilities  (as reported)30,381,000
Long-term Liabilities  (calculated)30,381,000
+/-0
Total Stockholder Equity
Common Stock25,189,000
Total Stockholder Equity (as reported)25,189,000
Total Stockholder Equity (calculated)25,189,000
+/-0
Other
Capital Stock107,000
Common Stock Shares Outstanding 800,579
Net Debt 23,435,000
Net Invested Capital 52,939,000
Net Tangible Assets 2,294,000
Net Working Capital 2,912,000



Balance Sheet

Currency in CHF. All numbers in thousands.

 Trend2022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-302020-06-302020-03-312019-12-312019-09-302019-06-302019-03-312018-12-312018-09-302018-06-302018-03-312017-12-312017-09-302017-06-302017-03-31
> Total Assets 
71,625,960
74,974,434
78,674,328
78,682,401
81,824,367
78,678,543
79,809,921
79,988,794
80,992,305
80,194,000
84,601,705
83,091,000
0
80,363,000
0
86,138,000
0
87,887,000
0
92,317,000
0
86,736,000
86,736,000092,317,000087,887,000086,138,000080,363,000083,091,00084,601,70580,194,00080,992,30579,988,79479,809,92178,678,54381,824,36778,682,40178,674,32874,974,43471,625,960
   > Total Current Assets 
26,589,572
27,832,620
32,394,829
32,398,153
30,977,601
29,786,634
32,774,954
32,848,411
32,636,685
32,315,000
31,254,000
31,254,000
27,703,000
27,703,000
32,942,000
32,942,000
31,260,000
31,260,000
35,627,000
35,627,000
30,321,000
30,321,000
30,321,00030,321,00035,627,00035,627,00031,260,00031,260,00032,942,00032,942,00027,703,00027,703,00031,254,00031,254,00032,315,00032,636,68532,848,41132,774,95429,786,63430,977,60132,398,15332,394,82927,832,62026,589,572
       Cash And Cash Equivalents 
3,442,329
3,603,256
4,841,986
4,842,483
5,540,088
5,327,093
6,791,014
6,806,235
5,745,632
5,689,000
6,185,452
6,075,000
0
3,770,000
0
5,727,000
0
5,000,000
0
6,850,000
0
4,315,000
4,315,00006,850,00005,000,00005,727,00003,770,00006,075,0006,185,4525,689,0005,745,6326,806,2356,791,0145,327,0935,540,0884,842,4834,841,9863,603,2563,442,329
       Short-term Investments 
3,471,239
3,633,518
7,467,679
7,468,445
3,862,257
3,713,768
2,218,947
2,223,920
5,537,581
5,483,000
3,535,126
5,783,000
0
2,482,000
0
6,607,000
0
3,017,000
0
6,181,000
0
2,493,000
2,493,00006,181,00003,017,00006,607,00002,482,00005,783,0003,535,1265,483,0005,537,5812,223,9202,218,9473,713,7683,862,2577,468,4457,467,6793,633,5183,471,239
       Net Receivables 
9,496,561
9,940,520
11,581,162
11,582,350
11,205,778
10,774,960
11,588,738
11,614,711
12,069,968
11,760,000
11,964,000
11,964,000
11,855,000
11,855,000
11,699,000
11,699,000
11,809,000
11,809,000
12,628,000
12,628,000
11,078,000
11,078,000
11,078,00011,078,00012,628,00012,628,00011,809,00011,809,00011,699,00011,699,00011,855,00011,855,00011,964,00011,964,00011,760,00012,069,96811,614,71111,588,73810,774,96011,205,77811,582,35011,581,1629,940,5209,496,561
       Inventory 
7,693,151
8,052,802
7,600,041
7,600,821
7,659,619
7,365,137
6,730,026
6,745,110
6,639,442
6,574,000
6,055,000
6,055,000
6,787,000
6,787,000
7,194,000
7,194,000
8,319,000
8,319,000
7,715,000
7,715,000
8,292,000
8,292,000
8,292,0008,292,0007,715,0007,715,0008,319,0008,319,0007,194,0007,194,0006,787,0006,787,0006,055,0006,055,0006,574,0006,639,4426,745,1106,730,0267,365,1377,659,6197,600,8217,600,0418,052,8027,693,151
       Other Current Assets 
2,486,292
2,602,525
325,262
325,295
2,709,860
2,605,676
420,817
421,760
2,644,061
2,618,000
574,000
574,000
2,809,000
2,809,000
553,000
553,000
3,115,000
3,115,000
382,000
382,000
4,143,000
4,143,000
4,143,0004,143,000382,000382,0003,115,0003,115,000553,000553,0002,809,0002,809,000574,000574,0002,618,0002,644,061421,760420,8172,605,6762,709,860325,295325,2622,602,5252,486,292
   > Long-term Assets 
0
0
0
0
0
0
0
0
0
47,879,000
0
51,837,000
0
52,660,000
0
53,196,000
0
56,627,000
0
56,690,000
0
56,415,000
56,415,000056,690,000056,627,000053,196,000052,660,000051,837,000047,879,000000000000
       Property Plant Equipment 
19,736,816
20,659,501
21,457,008
21,459,210
22,221,059
21,366,747
22,177,272
22,226,976
23,163,000
23,163,000
23,318,000
23,318,000
23,247,000
23,247,000
23,270,000
23,270,000
24,300,000
24,300,000
24,412,000
24,412,000
24,324,000
24,324,000
24,324,00024,324,00024,412,00024,412,00024,300,00024,300,00023,270,00023,270,00023,247,00023,247,00023,318,00023,318,00023,163,00023,163,00022,226,97622,177,27221,366,74722,221,05921,459,21021,457,00820,659,50119,736,816
       Goodwill 
10,734,722
11,236,565
10,339,627
10,340,688
12,091,271
11,626,409
9,095,345
9,115,729
8,966,378
8,878,000
12,682,467
12,456,000
0
10,109,000
0
9,249,000
0
10,623,000
0
10,809,000
0
11,160,000
11,160,000010,809,000010,623,00009,249,000010,109,000012,456,00012,682,4678,878,0008,966,3789,115,7299,095,34511,626,40912,091,27110,340,68810,339,62711,236,56510,734,722
       Long Term Investments 
0
0
597,168
597,229
0
0
611,913
613,284
0
0
752,436
990,299
0
0
0
0
0
0
0
0
0
0
0000000000990,299752,43600613,284611,91300597,229597,16800
       Intangible Assets 
9,392,882
9,831,994
8,586,087
8,586,968
10,957,714
10,536,433
9,499,898
9,521,190
9,168,368
9,078,000
8,509,960
8,358,000
0
11,394,000
0
12,017,000
0
12,510,000
0
12,117,000
0
11,735,000
11,735,000012,117,000012,510,000012,017,000011,394,00008,358,0008,509,9609,078,0009,168,3689,521,1909,499,89810,536,43310,957,7148,586,9688,586,0879,831,9949,392,882
       Long-term Assets Other 
0
0
0
0
0
0
0
0
0
1,305,000
0
451,000
0
1,939,000
0
617,000
0
2,199,000
0
834,000
0
2,046,000
2,046,0000834,00002,199,0000617,00001,939,0000451,00001,305,000000000000
> Total Liabilities 
46,425,082
48,595,429
48,911,348
48,916,367
50,261,671
48,329,308
48,943,891
49,053,586
49,667,551
49,178,000
48,082,595
47,224,000
0
45,548,000
0
46,365,000
0
46,454,000
0
63,972,000
0
57,790,000
57,790,000063,972,000046,454,000046,365,000045,548,000047,224,00048,082,59549,178,00049,667,55149,053,58648,943,89148,329,30850,261,67148,916,36748,911,34848,595,42946,425,082
   > Total Current Liabilities 
20,543,316
21,503,704
22,737,533
22,739,867
24,113,460
23,186,393
23,412,279
23,464,751
23,679,397
23,446,000
24,119,000
24,119,000
22,463,000
22,463,000
25,401,000
25,401,000
25,193,000
25,193,000
38,416,000
38,416,000
27,409,000
27,409,000
27,409,00027,409,00038,416,00038,416,00025,193,00025,193,00025,401,00025,401,00022,463,00022,463,00024,119,00024,119,00023,446,00023,679,39723,464,75123,412,27923,186,39324,113,46022,739,86722,737,53321,503,70420,543,316
       Short-term Debt 
21,049,746
22,033,810
2,425,611
2,425,859
1,391,040
1,337,560
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
00000000000000001,337,5601,391,0402,425,8592,425,61122,033,81021,049,746
       Short Long Term Debt 
21,049,746
22,033,810
2,425,611
2,425,859
1,391,040
1,337,560
2,170,157
2,175,020
2,904,630
4,173,000
294,254
1,695,000
0
2,552,000
0
3,996,000
0
3,726,000
0
15,122,000
0
5,381,000
5,381,000015,122,00003,726,00003,996,00002,552,00001,695,000294,2544,173,0002,904,6302,175,0202,170,1571,337,5601,391,0402,425,8592,425,61122,033,81021,049,746
       Accounts payable 
2,682,684
2,808,098
3,113,072
3,113,391
3,027,004
2,910,628
2,893,881
2,900,367
3,282,353
3,250,000
3,391,000
3,391,000
3,042,000
3,042,000
3,317,000
3,317,000
4,241,000
4,241,000
4,115,000
4,115,000
3,896,000
3,896,000
3,896,0003,896,0004,115,0004,115,0004,241,0004,241,0003,317,0003,317,0003,042,0003,042,0003,391,0003,391,0003,250,0003,282,3532,900,3672,893,8812,910,6283,027,0043,113,3913,113,0722,808,0982,682,684
       Other Current Liabilities 
13,490,180
14,120,839
5,968,603
5,969,215
16,120,996
15,501,208
10,910,754
10,935,208
16,000,712
9,929,000
7,418,000
7,418,000
16,830,000
16,830,000
9,895,000
9,895,000
17,226,000
17,226,000
9,737,000
9,737,000
18,132,000
18,132,000
18,132,00018,132,0009,737,0009,737,00017,226,00017,226,0009,895,0009,895,00016,830,00016,830,0007,418,0007,418,0009,929,00016,000,71210,935,20810,910,75415,501,20816,120,9965,969,2155,968,60314,120,83913,490,180
   > Long-term Liabilities 
0
0
0
0
0
0
0
0
0
25,732,000
0
23,105,000
0
23,085,000
0
20,964,000
0
21,261,000
0
25,556,000
0
30,381,000
30,381,000025,556,000021,261,000020,964,000023,085,000023,105,000025,732,000000000000
       Capital Lease Obligations 
0
0
0
0
0
0
0
0
0
0
0
1,219,000
0
0
0
1,195,000
0
0
0
1,354,000
0
0
001,354,0000001,195,0000001,219,00000000000000
       Long-term Liabilities Other 
0
0
0
0
0
0
0
0
0
976,000
0
93,000
0
1,228,000
0
75,000
0
1,230,000
0
36,000
0
1,347,000
1,347,000036,00001,230,000075,00001,228,000093,0000976,000000000000
> Total Stockholder Equity
22,745,489
23,808,828
27,130,105
27,132,889
28,625,707
27,525,161
28,076,845
28,139,772
28,338,318
28,059,000
33,342,384
32,747,000
0
31,509,000
0
36,341,000
0
37,814,000
0
24,489,000
0
25,189,000
25,189,000024,489,000037,814,000036,341,000031,509,000032,747,00033,342,38428,059,00028,338,31828,139,77228,076,84527,525,16128,625,70727,132,88927,130,10523,808,82822,745,489
   Common Stock
159,506
166,962
164,170
164,187
167,469
161,031
162,635
162,999
160,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000
160,000
25,189,000
25,189,000
25,189,00025,189,000160,000160,000160,000160,000160,000160,000160,000160,000160,000160,000160,000160,000162,999162,635161,031167,469164,187164,170166,962159,506
   Retained Earnings 
30,203,370
31,615,361
34,132,978
34,136,480
35,786,058
34,410,225
35,510,266
35,589,853
35,527,000
35,527,000
40,524,000
40,524,000
39,816,000
39,816,000
45,571,000
45,571,000
46,686,000
46,686,000
34,161,000
34,161,000
0
35,740,000
35,740,000034,161,00034,161,00046,686,00046,686,00045,571,00045,571,00039,816,00039,816,00040,524,00040,524,00035,527,00035,527,00035,589,85335,510,26634,410,22535,786,05834,136,48034,132,97831,615,36130,203,370
   Capital Surplus 0000000000000000000000
   Treasury Stock0000000000000000000000
   Other Stockholders Equity 00-9,832,000-9,832,000-9,032,000-9,032,000-9,390,000-9,390,000-8,467,000-8,467,000-7,937,000-7,937,000-7,628,000-7,628,000-7,613,081-7,596,056-7,046,095-7,327,821-7,167,778-7,167,043-7,973,495-7,617,386



Balance Sheet

Currency in CHF. All numbers in thousands.




Cash Flow

Currency in CHF. All numbers in thousands.




Income Statement

Currency in CHF. All numbers in thousands.


Latest Income Statement (annual, 2021-12-31)

Gross Profit (+$)
totalRevenue62,801,000
Cost of Revenue-19,647,000
Gross Profit43,154,00043,154,000
 
Operating Income (+$)
Gross Profit43,154,000
Operating Expense-44,646,000
Operating Income18,155,000-1,492,000
 
Operating Expense (+$)
Research Development14,799,000
Selling General Administrative13,249,000
Selling And Marketing Expenses-
Operating Expense44,646,00028,048,000
 
Net Interest Income (+$)
Interest Income-
Interest Expense-419,000
Net Interest Income-414,000-419,000
 
Pretax Income (+$)
Operating Income18,155,000
Net Interest Income-414,000
Other Non-Operating Income Expenses-
Income Before Tax (EBT)17,398,00018,155,000
EBIT - interestExpense = 19,768,000
16,393,000
14,349,000
Interest Expense419,000
Earnings Before Interest and Taxes (ebit)20,187,00017,817,000
Earnings Before Interest and Taxes (ebitda)22,260,000
 
After tax Income (+$)
Income Before Tax17,398,000
Tax Provision-2,463,000
Net Income From Continuing Ops14,935,00014,935,000
Net Income13,930,000
Net Income Applicable To Common Shares13,930,000
 
Non-recurring Events
Discontinued Operations-
Extraordinary Items-
Effect of Accounting Charges-
Other Items-
Non Recurring-
Other Operating Expenses238,000
Total Other Income/Expenses Net-414,000
 

Comments

Join the conversation.

Leave a comment

Stay informed with my latest content.

Subscribe to my newsletter and receive an email as soon as I add content to PenkeTrading.com.


By clicking Register, you agree to the General Terms and Conditions.
Penke's Market Notifications
UETW.XETRA
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of UETW.XETRA.

UETW.XETRA Daily Candlestick Chart
PLUN.XETRA
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of PLUN.XETRA.

PLUN.XETRA Daily Candlestick Chart
LYYA.XETRA
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LYYA.XETRA.

LYYA.XETRA Daily Candlestick Chart
IUSP.XETRA
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IUSP.XETRA.

IUSP.XETRA Daily Candlestick Chart
SXR3.XETRA
1 minute ago

I found you a Death Cross on the daily chart of SXR3.XETRA.

SXR3.XETRA Daily Candlestick Chart
EDM4.XETRA
1 minute ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EDM4.XETRA.

EDM4.XETRA Daily Candlestick Chart
LYM8.XETRA
3 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of LYM8.XETRA.

LYM8.XETRA Daily Candlestick Chart
IS3T.XETRA
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IS3T.XETRA.

IS3T.XETRA Daily Candlestick Chart
IS3S.XETRA
7 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of IS3S.XETRA.

IS3S.XETRA Daily Candlestick Chart
IS3Q.XETRA
7 minutes ago

I found you a Death Cross on the daily chart of IS3Q.XETRA.

IS3Q.XETRA Daily Candlestick Chart
H4ZJ.F
10 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of H4ZJ.F.

H4ZJ.F Daily Candlestick Chart
H4ZH.F
11 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of H4ZH.F.

H4ZH.F Daily Candlestick Chart
H4ZB.F
11 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of H4ZB.F.

H4ZB.F Daily Candlestick Chart
H4ZA.F
11 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of H4ZA.F.

H4ZA.F Daily Candlestick Chart
GC40.XETRA
11 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of GC40.XETRA.

GC40.XETRA Daily Candlestick Chart
EMSM.F
15 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EMSM.F.

EMSM.F Daily Candlestick Chart
EMWE.F
15 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EMWE.F.

EMWE.F Daily Candlestick Chart
ELFW.F
15 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ELFW.F.

ELFW.F Daily Candlestick Chart
EJAH.F
15 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EJAH.F.

EJAH.F Daily Candlestick Chart
EHDL.F
15 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of EHDL.F.

EHDL.F Daily Candlestick Chart
XACT-SVERIGE.ST
21 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of XACT-SVERIGE.ST.

XACT-SVERIGE.ST Daily Candlestick Chart
FASTAT.ST
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of FASTAT.ST.

FASTAT.ST Daily Candlestick Chart
ESSITY-B.ST
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of ESSITY-B.ST.

ESSITY-B.ST Daily Candlestick Chart
CISH.ST
23 minutes ago

I found you a STOCH Bullish Reversal Divergence on the daily chart of CISH.ST.

CISH.ST Daily Candlestick Chart
CIRCHE.ST
23 minutes ago

I found you a Oversold RSI (Relative Strength Index) on the daily chart of CIRCHE.ST.

CIRCHE.ST Daily Candlestick Chart